Education
About Us
Working with TipRanks
Follow Us
AVIE - ETF AI Analysis
Top Page
Avantis Inflation Focused Equity ETF (AVIE)
Rating:71Outperform
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Inflation-Resilient Sector Tilt
Heavy exposure to health care, energy, and consumer defensive stocks can help the fund hold up better when inflation is elevated.
Reasonable Expense Ratio
The fund’s fee is moderate for an actively managed, specialized strategy, allowing investors to keep more of their returns.
Negative Factors
Very Small Fund Size
With relatively low assets under management, the ETF may face higher trading spreads and a greater risk of closure than larger funds.
High U.S. Concentration
Almost all of the portfolio is invested in U.S. companies, offering little geographic diversification.
Mixed Performance Among Top Holdings
Some of the largest positions, such as Berkshire Hathaway and AbbVie, have been weak this year, which can drag on overall returns if the trend continues.
AVIE vs. SPDR S&P 500 ETF (SPY)
AUM8.79M
RegionNorth America
Expense Ratio0.25%
Beta0.51
IssuerAvantis
Inception DateSep 27, 2022
Dividend Yield1.57%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,054
30 Day Avg. Volume860
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
77.71Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering345
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AVIE Summary
Avantis Inflation Focused Equity ETF (AVIE) is a U.S.-focused stock fund that aims to hold companies that may handle rising prices well, rather than tracking a specific index. It owns a mix of large, mid, and small companies, with big weights in health care, energy, and consumer staples. Well-known holdings include Berkshire Hathaway and Exxon Mobil. Someone might invest in AVIE to seek long-term growth while trying to protect their money from inflation and gain broad diversification across sectors. A key risk is that stock prices can still go up and down significantly with the overall market.
How much will it cost me?The Avantis Inflation Focused Equity ETF (AVIE) has an expense ratio of 0.25%, which means you’ll pay $2.50 per year for every $1,000 invested. This cost is lower than average for actively managed ETFs because it focuses on inflation-conscious equity investments while maintaining broad market exposure.
What would affect this ETF?The Avantis Inflation Focused Equity ETF (AVIE) could benefit from rising inflation, as its focus on companies with strong pricing power and fundamentals may help it perform well in such environments. Positive trends in sectors like Health Care and Energy, which make up a significant portion of its holdings, could also drive growth. However, economic slowdowns or regulatory changes affecting key sectors like Energy or Financials, as well as declining inflation concerns, could negatively impact its performance.
AVIE Top 10 Holdings
AVIE leans heavily into U.S. health care, energy, and defensive staples, building an inflation-ready core rather than chasing high-flying tech. Exxon and Chevron have been rising and act as the fund’s energy engine, while Eli Lilly and Johnson & Johnson give health care a strong, steady heartbeat. Consumer giants like Procter & Gamble and PepsiCo add stability, even if their recent performance has been more mixed. The main drag comes from Berkshire Hathaway and AbbVie, which have been lagging and slightly dulling the fund’s overall momentum.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Berkshire Hathaway B | 6.18% | $542.66K | $1.08T | 3.80% | 66 Neutral | |
| Exxon Mobil | 5.95% | $522.66K | $635.44B | 36.39% | 74 Outperform | |
| Eli Lilly & Co | 3.89% | $341.76K | $962.75B | 15.55% | 72 Outperform | |
| Procter & Gamble | 3.47% | $304.75K | $364.54B | -6.86% | 69 Neutral | |
| Chevron | 3.03% | $266.08K | $370.23B | 17.75% | 71 Outperform | |
| Johnson & Johnson | 2.38% | $209.13K | $590.40B | 52.13% | 78 Outperform | |
| AbbVie | 2.34% | $205.06K | $404.24B | 11.02% | 66 Neutral | |
| PepsiCo | 2.32% | $203.76K | $224.66B | 7.45% | 78 Outperform | |
| Philip Morris | 2.24% | $196.53K | $284.36B | 18.85% | 61 Neutral | |
| Coca-Cola | 2.05% | $179.60K | $341.93B | 10.60% | 75 Outperform |
AVIE Technical Analysis
Positive
―
Price Trends
68.34
Positive
65.96
Positive
63.25
Positive
Market Momentum
1.46
Negative
73.34
Negative
75.15
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AVIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 71.24, equal to the 50-day MA of 68.34, and equal to the 200-day MA of 63.25, indicating a bullish trend. The MACD of 1.46 indicates Negative momentum. The RSI at 73.34 is Negative, neither overbought nor oversold. The STOCH value of 75.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVIE.
AVIE Peer Comparison
Comparison Results
Performance Comparison
AVIE
Avantis Inflation Focused Equity ETF
73.26
11.50
18.62%
BAMD
Brookstone Dividend Stock ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
RFDA
RiverFront Dynamic US Dividend Advantage ETF
―
―
―
VAMO
Cambria Value & Momentum ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents